The first postmodern pandemic: 25 Years of HIV/AIDS

Journal of Internal Medicine

Volumn 263, Issue 3, 2008, Pages 218-243

  Kallings, L O ^a,b,c  

^a Clinical Microbiology

^b International AIDS Society

^c NONE   (Sweden)

Author keywords

Epidemiology; HIV; Origin; Prevention; Socioeconomic consequences; Treatments

Indexed keywords

CHEMOKINE RECEPTOR CCR5 ANTAGONIST; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTEGRASE INHIBITOR; NONOXINOL 9; NUCLEOSIDE ANALOG; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANEMIA; ANTIVIRAL THERAPY; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE TRANSMISSION; DRUG USE; FINANCIAL MANAGEMENT; FUNDING; HEALTH CARE; HEALTH CARE SYSTEM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INFECTION PREVENTION; MONOTHERAPY; NONHUMAN; PANDEMIC; PATHOGENESIS; POLITICS; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RISK REDUCTION; SEXUAL INTERCOURSE; SOCIAL ASPECT; SOCIOECONOMICS; VACCINATION; VAGINA DISEASE; VAGINAL WALL ABRASION; VAGINITIS;

ADULT; AFRICA; AIDS VACCINES; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DISEASE OUTBREAKS; FEMALE; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; WORLD HEALTH;

EID: 38849204230     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2007.01910.x     Document Type: Review

References (45)

1. Jarrett WF. Experimental studies of feline and bovine leukemia. Proc R Soc Med 1966 59 : 661 2.
2. Jarrett W, Jarrett O, Mackey L, Laird H, Hardy Jr. W, Essex M. Horizontal transmission of leukemia virus and leukemia in the cat. J Natl Cancer Inst 1973 51 : 833 41.
3. Essex ME. Feline leukemia: a naturally occurring cancer of infectious origin. Epidemiol Rev 1982 4 : 189 203.
4. Huebner RJ, Todaro GJ. Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A 1969 64 : 1087 94.
5. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001 409 : 860 921.
6. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980 77 : 7415 9.
7. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982 218 : 571 3.
8. Hinuma Y, Nagata K, Hanaoka M et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies of the antigen in human sera. Proc Natl Acad Sci U S A 1981 78 : 6476 80.
9. Robert-Guroff M, Kalyanaraman VS, Blattner WA et al. Evidence for human T cell lymphoma-leukemia virus infection of family members of human T cell lymphoma-leukemia virus positive T cell leukemia-lymphoma patients. J Exp Med 1983 157 : 248 58.
10. de-Thé G, Gessain A, Gazzolo L et al. Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries. Cancer Res 1985 45 (9 Suppl. 4633s 6s.
11. Temin HM, Mizutani S. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 1970 226 : 1211 3.
12. Baltimore D. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 1970 226 : 1209 11.
13. Morgan DA, Ruscetti FW, Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 1976 193 : 1007 8.
14. Popovic M, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984 224 : 497 500.
15. Gallo RC. Historical essay. The early years of HIV/AIDS. Science 2002 298 : 1728 30.
16. Barré-Sinoussi F, Chermann JC, Rey F et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983 220 : 868 71.
17. Prusiner SB. Historical essay. Discovering the cause of AIDS. Science 2002 298 : 1726.
18. Montagnier L. Historical essay. A history of HIV discovery. Science 2002 298 : 1727 8.
19. Coffin J, Haase A, Levy JA et al. Human immunodeficiency viruses. Science 1986 232 : 697.
20. Downing RG, Eglin RP, Bayley AC. African Kaposi's sarcoma and AIDS. Lancet 1984 1 : 478 80.
21. Bayley AC. Aggressive Kaposi's sarcoma in Zambia, 1983. Lancet 1984 1 : 1318 20.
22. Stekler J, Coombs RW. Transmitted HIV-1 drug resistance: are we seeing just the tip of an epidemiological iceberg? J Infect Dis 2007 196 : 336 8. Epub 2007 Jun 19.
23. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2006 Report on the Global AIDS Epidemic. A UNAIDS 10th Anniversary Special Edition. UNAIDS : Geneva, Switzerland, 2006.
24. WHO/UNAIDS. New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications. WHO/UNAIDS : Montreaux, 2007.
25. Korber B, Muldoon M, Theiler J et al. Timing the ancestor of the HIV-1 pandemic strains. Science 2000 288 : 1789 96.
26. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: scientific and public health implications. Science 2000 287 : 607 14.
27. Williams G, Stretton TB, Leonard JC. Cytomegalic inclusion disease and Pneumocystis carinii infection in an adult. Lancet 1960 2 : 951 5.
28. Zhu T, Korber BT, Nahmias AJ, Hooper E, Sharp PM, Ho DD. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998 391 : 594 7.
29. Van de Perre P, Rouvroy D, Lepage P et al. Acquired immunodeficiency syndrome in Rwanda. Lancet 1984 2 : 62 5.
30. Van de Perre P, Le Polain B, Carael M, Nzaramba D, Zissis G, Butzler JP. HIV antibodies in a remote rural area in Rwanda, Central Africa: an analysis of potential risk factors for HIV seropositivity. AIDS 1987 1 : 213 5.
31. Centers for Disease Control (CDC). Pneumocystis pneumonia - Los Angeles. MMWR 1981 30 : 250 2.
32. CDC. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. MMWR 1981 30 : 305 8.
33. Gilbert MT, Rambaut A, Wlasiuk G, Spira TJ, Pitchenik AE, Worobey M. The emergence of HIV/AIDS in the Americas and beyond. Proc Natl Acad Sci U S A. 2007 104 : 18566 70.
34. Dorrington RE, Johnson LF, Bradshaw D, Daniel T. The Demographic Impact of HIV/AIDS in South Africa. National and Provincial Indicators for 2006. Cape Town : Centre for Actuarial Research, South African Medical Research Council and Actuarial Society of South Africa. 2006.
35. Caraël M, Holmes KK. Dynamics of HIV epidemics in sub-Saharan Africa: introduction. AIDS 2001 15 (Suppl. 4 S1 4.
36. Ferry B, Caraël M, Buvé A et al. Study Group on Heterogeneity of HIV Epidemics in African Cities. Comparison of key parameters of sexual behaviour in four African urban populations with different levels of HIV infection. AIDS 2001 15 (Suppl. 4 S41 50.
37. Carael M, Glynn R, Lagarde E, Morison L. Sexual networks and HIV in four African populations. In : M Morris, ed Network Epidemiology. Oxford : Oxford University Press, 2004 58 84.
38. Halperin DT, Epstein H. Concurrent sexual partnerships help to explain Africa's high HIV prevalence: implications for prevention. Lancet 2004 364 : 4 6.
39. UNAIDS. Financial Resources Required to Achieve Universal Access to HIV Prevention, Treatment, Care and Support. UNAIDS : Geneva, 2007.
40. World Bank warning. AIDS to cause complete economic collapse within 3 generations. S Afr Med J 2003 93 : 745 6.
41. Duesberg P, Koehnlein C, Rasnick D. The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition. J Biosci 2003 28 : 383 412.
42. [No author listed]. The Durban Declaration. Nature 2000 406 : 15 6.
43. Brown AE, McNeil JG. HIV vaccine development: a subtype E-specific strategy. Southeast Asian J Trop Med Public Health 1998 29 : 377 82.
44. Anderson JP, Rodrigo AG, Learn GH et al. Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E. J Virol 2000 74 : 10 752 65.
45. Abecasis AB, Lemey P, Vidal N et al. Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form. J Virol 2007 81 : 8543 51.